Research
The Overlapping History of Beta-Blockers and Psilocybin
By Trey Brasher Beta-blockers are a class of drugs most commonly prescribed for reducing hypertension (lowering blood pressure) and widely
Scroll through our posts for psychedelic FAQs, Unlimited Sciences research updates, and other news within the psychedelic space!
By Trey Brasher Beta-blockers are a class of drugs most commonly prescribed for reducing hypertension (lowering blood pressure) and widely
People of varied religious backgrounds have associated psychedelics with enlightenment and spiritual practices for thousands of years. Records from 3780
Last month, we had the honor of welcoming Dr. Gunther Weil, the only remaining member of the Harvard Psilocybin Project,
The term ego derived its modern meaning from the work of psychologist Sigmund Freud. In this blanket term, he encompassed
Psychedelic experiences can be so ineffable and beyond the scope of our everyday lives, that we can’t just assume we’ll
By Trey Brasher On April 19th, 1943 in Basil, Switzerland, chemist Albert Hofmann took the world’s first trip on LSD.
The majority of psychedelics research is focused on health-related outcomes of full-dose psychedelics, but the increasing popularity of microdosing warrants
Until recently, the only way to have an experience of an MDMA ‘roll’ was curtesy of clandestine chemists working in
Although undoubtedly the obsessive self-destructive drug seeking behavior seen in drug addiction is indeed pathological, this represents the extreme in
Research Director Matthew Lowe is no stranger to the world of neuroscience and psychedelics. As previous Director of Research at
©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.